Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path forward for psychedelic-based medicines.
Related Posts
Auto & Transport Roundup: Market Talk
Read about ComfortDelGro, MISC and more in the latest Market Talks covering the Auto and Transport sector.
DBS Names CEO Successor
The Singapore banking heavyweight also raised guidance and reported a quarterly profit beat.
General Motors Scraps Cruise Robotaxi Program
Carmaker cites competition, time and costs needed to scale the business.